JP2019526543A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526543A5 JP2019526543A5 JP2019506143A JP2019506143A JP2019526543A5 JP 2019526543 A5 JP2019526543 A5 JP 2019526543A5 JP 2019506143 A JP2019506143 A JP 2019506143A JP 2019506143 A JP2019506143 A JP 2019506143A JP 2019526543 A5 JP2019526543 A5 JP 2019526543A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- cancer
- antigen
- patient
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 1
- 102000038129 antigens Human genes 0.000 claims 1
- 108091007172 antigens Proteins 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
Claims (1)
- 患者の癌を治療する為の剤であって、当該剤が請求項１乃至請求項７のいずれか１項に記載のナノ粒子組成物を含んでおり、該癌が前記抗原を発現する、前記剤。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022131006A JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662371668P | 2016-08-05 | 2016-08-05 | |
| US62/371,668 | 2016-08-05 | ||
| US201662409830P | 2016-10-18 | 2016-10-18 | |
| US62/409,830 | 2016-10-18 | ||
| PCT/US2017/045643 WO2018027205A1 (en) | 2016-08-05 | 2017-08-04 | Modified antibody-albumin nanoparticle complexes for cancer treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022131006A Division JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019526543A JP2019526543A (ja) | 2019-09-19 |
| JP2019526543A5 true JP2019526543A5 (ja) | 2020-09-17 |
| JP7158372B2 JP7158372B2 (ja) | 2022-10-21 |
Family
ID=59677326
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019506143A Active JP7158372B2 (ja) | 2016-08-05 | 2017-08-04 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
| JP2022131006A Pending JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022131006A Pending JP2022161992A (ja) | 2016-08-05 | 2022-08-19 | 癌治療のための修飾抗体－アルブミンナノ粒子複合体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210267930A1 (ja) |
| EP (1) | EP3493854B1 (ja) |
| JP (2) | JP7158372B2 (ja) |
| KR (2) | KR102482503B1 (ja) |
| CN (1) | CN109922836A (ja) |
| AU (1) | AU2017307618A1 (ja) |
| CA (1) | CA3032947A1 (ja) |
| IL (1) | IL264598A (ja) |
| MX (1) | MX2019001517A (ja) |
| RU (1) | RU2019105550A (ja) |
| WO (1) | WO2018027205A1 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2707030B1 (en) | 2011-05-09 | 2020-02-19 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| AU2013327638B2 (en) | 2012-10-01 | 2018-06-14 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| CN106604750B (zh) | 2014-06-16 | 2021-05-07 | 梅约医学教育与研究基金会 | 治疗骨髓瘤 |
| US9446148B2 (en) | 2014-10-06 | 2016-09-20 | Mayo Foundation For Medical Education And Research | Carrier-antibody compositions and methods of making and using the same |
| TW201707725A (zh) | 2015-08-18 | 2017-03-01 | 美國馬友醫藥教育研究基金會 | 載體－抗體組合物及其製造及使用方法 |
| TW201713360A (en) | 2015-10-06 | 2017-04-16 | Mayo Foundation | Methods of treating cancer using compositions of antibodies and carrier proteins |
| US11571469B2 (en) | 2016-01-07 | 2023-02-07 | Mayo Foundation For Medical Education And Research | Methods of treating cancer with interferon wherein the cancer cells are HLA negative or have reduced HLA expression |
| WO2017165439A1 (en) | 2016-03-21 | 2017-09-28 | Mayo Foundation For Medical Education And Research | Methods for improving the therapeutic index for a chemotherapeutic drug |
| CA3018341A1 (en) | 2016-03-21 | 2017-09-28 | Mayo Foundation For Medical Education And Research | Methods for reducing toxicity of a chemotherapeutic drug |
| US10618969B2 (en) | 2016-04-06 | 2020-04-14 | Mayo Foundation For Medical Education And Research | Carrier-binding agent compositions and methods of making and using the same |
| CA3035377A1 (en) | 2016-09-01 | 2018-03-08 | Mayo Foundation For Medical Education And Research | Nanoparticle compositions for targeting t-cell cancers |
| MX2019002474A (es) | 2016-09-01 | 2019-09-18 | Mayo Found Medical Education & Res | Composiciones de agente de unión de portador-ligando-1 de muerte programada y métodos de uso de las mismas para el tratamiento de cánceres. |
| WO2018048958A1 (en) | 2016-09-06 | 2018-03-15 | Mayo Foundation For Medical Education And Research | Paclitaxel-albumin-binding agent compositions and methods for using and making the same |
| RU2019110071A (ru) | 2016-09-06 | 2020-10-08 | Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч | Способы лечения злокачественных новообразований, экспрессирующих pd-l1 |
| EP3509635A1 (en) | 2016-09-06 | 2019-07-17 | Vavotar Life Sciences LLC | Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins |
| US11531030B2 (en) | 2017-04-21 | 2022-12-20 | Mayo Foundation For Medical Education And Research | Polypeptide-antibody complexes and uses thereof |
| US20210023233A1 (en) * | 2018-02-06 | 2021-01-28 | Mayo Foundation For Medical Education And Research | Antibody-peptide complexes and uses thereof |
| JP7308507B2 (ja) * | 2019-01-31 | 2023-07-14 | Ｓｐｉｂｅｒ株式会社 | 組換え構造タンパク質の製造方法及び分析方法、並びにタンパク質成形体の製造方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| SI1585548T1 (sl) | 2002-12-09 | 2018-11-30 | Abraxis Bioscience, Llc | Sestave in metode odmerjanja farmakoloških sredstev |
| ES2662848T3 (es) * | 2004-05-14 | 2018-04-10 | Abraxis Bioscience, Llc | Composiciones farmacéuticas de suministro en el sitio de enfermedad que comprenden paclitaxel |
| WO2006034455A2 (en) * | 2004-09-23 | 2006-03-30 | Vasgene Therapeutics, Inc. | Polipeptide compounds for inhibiting angiogenesis and tumor growth |
| SI3248600T1 (sl) | 2005-02-18 | 2020-09-30 | Abraxis Bioscience, Llc | Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija |
| US20070166388A1 (en) * | 2005-02-18 | 2007-07-19 | Desai Neil P | Combinations and modes of administration of therapeutic agents and combination therapy |
| MX2011005968A (es) * | 2008-12-05 | 2011-07-19 | Abraxis Bioscience Llc | Enfoque de enfermedad mediada por peptido enlazado a albumina. |
| AU2010251966A1 (en) * | 2009-05-28 | 2011-12-22 | Glaxo Group Limited | Combination of a TNF-alpha antagonist and a VEGF antagonist for use in the treatment or prevention of diseases of the eye. |
| EP2707030B1 (en) | 2011-05-09 | 2020-02-19 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| AU2013327638B2 (en) * | 2012-10-01 | 2018-06-14 | Mayo Foundation For Medical Education And Research | Cancer treatments |
| AU2015274408A1 (en) * | 2014-06-13 | 2017-01-12 | Mayo Foundation For Medical Education And Research | Treating lymphomas |
| HUE047393T2 (hu) * | 2014-10-06 | 2020-04-28 | Mayo Found Medical Education & Res | Szállító antitest komplexek és módszerek ezek hasznosítására |
| US9446148B2 (en) | 2014-10-06 | 2016-09-20 | Mayo Foundation For Medical Education And Research | Carrier-antibody compositions and methods of making and using the same |
| EP3533870A4 (en) * | 2016-10-28 | 2020-04-08 | NRL Pharma, Inc. | LACTOFERRIN / ALBUMIN FUSION PROTEIN AND PRODUCTION METHOD THEREFOR |
-
2017
- 2017-08-04 US US16/323,377 patent/US20210267930A1/en not_active Abandoned
- 2017-08-04 EP EP17754896.3A patent/EP3493854B1/en active Active
- 2017-08-04 WO PCT/US2017/045643 patent/WO2018027205A1/en unknown
- 2017-08-04 RU RU2019105550A patent/RU2019105550A/ru unknown
- 2017-08-04 KR KR1020197006118A patent/KR102482503B1/ko active IP Right Grant
- 2017-08-04 CN CN201780062131.4A patent/CN109922836A/zh active Pending
- 2017-08-04 JP JP2019506143A patent/JP7158372B2/ja active Active
- 2017-08-04 CA CA3032947A patent/CA3032947A1/en active Pending
- 2017-08-04 AU AU2017307618A patent/AU2017307618A1/en active Pending
- 2017-08-04 KR KR1020227045346A patent/KR20230006037A/ko not_active Application Discontinuation
- 2017-08-04 MX MX2019001517A patent/MX2019001517A/es unknown
-
2019
- 2019-02-03 IL IL264598A patent/IL264598A/en unknown
-
2022
- 2022-08-19 JP JP2022131006A patent/JP2022161992A/ja active Pending
-
2023
- 2023-01-11 US US18/153,286 patent/US20240058296A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526543A5 (ja) | ||
| JOP20200192A1 (ar) | أجسام مضادة لـ tigit | |
| JP2018012698A5 (ja) | ||
| JP2016523252A5 (ja) | ||
| JP2015503422A5 (ja) | ||
| JP2015173751A5 (ja) | ||
| JP2016540026A5 (ja) | ||
| JP2016540019A5 (ja) | ||
| WO2015160470A3 (en) | Nadph production by the 10-formyl-thf pathway, and its use in the diagnosis and treatment of disease | |
| JP2016535794A5 (ja) | 急速崩壊性固体剤形 | |
| JP2019526545A5 (ja) | ||
| WO2016057726A3 (en) | Human anti-vegfr-2/kdr antibodies | |
| JP2019074725A5 (ja) | ||
| CN302548735S (zh) | 酱料瓶 | |
| CN302591127S (zh) | 光子嫩肤机（Mask-Ⅱ） | |
| CN302465229S (zh) | 酱料挤压瓶 | |
| CN302554027S (zh) | 抽屉照明器 | |
| CN302509246S (zh) | 开罐器（1021） | |
| CN302509247S (zh) | 开罐器（1022） | |
| CN302487713S (zh) | 开罐器（1020） | |
| CN302421199S (zh) | 铰链 | |
| CN302524991S (zh) | 桶 | |
| CN302538253S (zh) | 手提包 | |
| CN302587526S (zh) | 分配器 | |
| CN302562258S (zh) | 蒸面器(nt520) |